Analyst firms · Jefferies · ALXO
Jefferies ALXO price target and rating history
ALX Oncology Holdings Inc. (ALXO) · Health Care
Jefferies rates ALX Oncology Holdings Inc. (ALXO) Buy with a $4 price target, as of its latest action on Nov 13, 2025. It has published 5 rating actions on ALXO since December 2021, including 2 upgrades and 2 downgrades. Across 3 firms with a ALXO price target in the last 12 months, the median target is $5. Jefferies's $4 is 20% below that.
- Current rating
- Buy
- Price target
- $4
- Median target, all firms
- $5
- Actions on ALXO
- 5
Jefferies price target on ALXO
Every Jefferies rating on ALXO
- Nov 13, 2025
- Mar 6, 2025
- Dec 19, 2024
- Dec 8, 2023
- Dec 22, 2021
How other firms rate ALXO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $5 | Mar 19, 2026 |
| UBS | Buy | $6 | Mar 6, 2026 |
| Jefferies | Buy | $4 | Nov 13, 2025 |
Questions about Jefferies and ALXO
- What is Jefferies's price target for ALXO?
- Jefferies's latest stated price target for ALX Oncology Holdings Inc. (ALXO) is $4, from its action on Nov 13, 2025.
- What is Jefferies's rating on ALXO?
- Jefferies rates ALXO Buy, a bullish rating, as of Nov 13, 2025.
- When did Jefferies last change its view on ALXO?
- On Nov 13, 2025, Jefferies starts coverage at Buy, price target $4.
- How does Jefferies's ALXO target compare with other analysts?
- Across 3 firms with a ALXO price target in the last 12 months, the median target is $5. Jefferies's $4 is 20% below that.
More ALXO rating histories
All Jefferies ratingsALXO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.